All In Biotech

NDA 202133 · Twi Pharms

Fluoxetine Hydrochloride

Fluoxetine Hydrochloride · Oral

Discontinued

Last checked: Nov 20, 2026Latest source record: Aug 18, 2023 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

2011

Oct 6, 2011

Approved uses

1

Original approval plus efficacy supplements

Registered trials

326

58 Phase 3, 28 recruiting

FAERS reports

13,085

9,897 serious, 1,521 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

No structured label for this application in openFDA. Older and discontinued products often have none.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

1 products under this application
  • FLUOXETINE HYDROCHLORIDE · FLUOXETINE HYDROCHLORIDE EQ 60MG BASE · TABLET, ORAL · Discontinued · TE AB

Clinical trials

Interventional ClinicalTrials.gov studies with "Fluoxetine" as an intervention, any sponsor and status, largest first.

All 326 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • headache934
  • drug ineffective876
  • off label use849
  • fatigue793
  • drug interaction789
  • nausea749
  • toxicity to various agents730
  • intentional overdose684
  • dizziness657
  • dyspnoea645
  • diarrhoea620
  • suicide attempt581

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
2004148
2005118
2006100
2007124
2008163
2009107
2010107
2011231
2012224
2013212
2014266
2015383
2016293
2017495
2018584
2019637
2020515
2021714
20221,352
20231,496
20241,738
20251,678
20261,400

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 2,245 on PubMed

Sponsor: Twi Pharms

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.